Enhancing the Vascularization Properties of Skin Tissue

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 2R44AG026903-02A1
Agency Tracking Number: AG026903
Amount: $608,811.00
Phase: Phase II
Program: SBIR
Awards Year: 2007
Solitcitation Year: 2007
Solitcitation Topic Code: N/A
Solitcitation Number: N/A
Small Business Information
STRATATECH CORPORATION
505 SOUTH ROSA ROAD, SUITE 169, MADISON, WI, 53719
Duns: 160392168
Hubzone Owned: N
Woman Owned: Y
Socially and Economically Disadvantaged: N
Principal Investigator
 ALLEN COMER
 (608) 441-2759
 acomer@stratatechcorp.com
Business Contact
 ALLEN COMER
Phone: (608) 441-2756
Email: acomer@stratatechcorp.com
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): To date no biological treatment options specifically targeting the hypoxic nature of chronic wounds have been developed and marketed. While administration of individual angiogenic factors may stimulate some aspects of angiogenesis, the simultaneous expression of multiple factors is required to promote morphologically and functionally normal vessels. In this Phase II study, we propose to characterize a human keratinocyte cell line genetically-modified to coordinately express elevated levels of multiple therapeutic factors. Advances in ex vivo genetic engineering of a patented human keratinocyte cell line at Stratatech Corporation has made it uniquely positioned to complete this work. If successful, the proposed research will ultimately lead to the development and commercialization of improved treatments to promote the healing of chronic wounds and other severe skin defects.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government